Market ResearchApril 12, 2024 The EU’s Plan for a €6.5M Study of Psychedelics To Treat Mental Disorders
PressApril 12, 2024 Red Light Holland’s Largest Psilocybin Shipment Received by CCrest Labs in Montreal with Health Canada Approved Import Permit
PressApril 11, 2024 Algernon Pharmaceuticals CEO Christopher J. Moreau to Be Featured on Radius Research’s Pitch, Deep Dive and Q&A Webinar on April 16th, 2024
PressApril 10, 2024 Silo Pharma set to Acquire Exclusive Licensing for Promising Alzheimer’s Disease Therapeutic
PressApril 10, 2024 Seaport Therapeutics Launches with $100 Million Oversubscribed Series a Financing Round to Advance Novel Neuropsychiatric Medicines
PressApril 10, 2024 Clearmind Medicine Files U.S. Patent Application for Psychedelic-Based Treatment for Eating Disorders
PressApril 9, 2024 Red Light Holland Launches Its Largest Psilocybin Shipment to Canada with Health Canada Approved Import Permit; Debenture Offering Successfully Closed
Market ResearchApril 8, 2024 Missouri Considers $10 Million from Opioid Settlements for Psilocybin Research
PressApril 5, 2024 Psilocybin Clinical Trial Sponsored by Clairvoyant Therapeutics Reaches 90% Randomization
Market ResearchApril 4, 2024 FSD Pharma Cuts Annual Losses to $18Million; Will Need More Capital to Develop
